Mr. Roy introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025. H.R. 1632. 119th
Cong., 1st
sess., Introduced in House February 26, 2025. https://www.govinfo.gov/app/details/BILLS-119hr1632ih.
APA
Congress, House of Representatives (2025, February 26). Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025 (H.R. 1632 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr1632ih.
MLA
United States, Congress, House of Representatives. Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr1632ih. 119th Congress, H.R. 1632, Introduced in House 26 Feb. 2025.
Bluebook
H.R.1632 - 119th Congress (2025-2026): Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025, H.R.1632, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hr1632ih.
